Philippe Prokocimer serves as Executive at Trius Therapeutics Inc, where they oversee executive responsibilities. Since joining the company, Philippe Prokocimer has executed 15 insider transactions totaling $348.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 11, 2013 involved selling 12,190 shares valued at $0.
Philippe Prokocimer currently holds 82,022 shares of Trius Therapeutics Inc (TSRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Philippe Prokocimer has been a net seller of TSRX stock. They have purchased $0 and sold $348.2K worth of shares.
Philippe Prokocimer's most recent insider trade was on Sep 11, 2013, when they sold 12,190 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 1, 2013 | TSRX | $16.3K | Sale | 2,000 | $8.14 | Discretionary |
| Jun 3, 2013 | TSRX | $15.5K | Sale | 2,000 | $7.75 | Discretionary |
| May 24, 2013 | TSRX | $95.2K | Sale | 12,000 | $7.93 | Discretionary |
| May 13, 2013 | TSRX | $91.8K | Sale | 12,000 | $7.65 | Discretionary |
| May 13, 2013 | TSRX | $91.8K | Sale | 12,000 | $7.65 | Discretionary |
| Mar 23, 2012 | TSRX | $3.2K | Option Exercise | 6,244 | $0.52 | Discretionary |
| Jan 13, 2012 | TSRX | $2.1K | Option Exercise | 4,000 | $0.52 | Discretionary |
| Jan 13, 2012 | TSRX | $2.1K | Option Exercise | 4,000 | $0.52 | Discretionary |
| Oct 31, 2011 | TSRX | $12.6K | Sale | 1,687 | $7.45 | Discretionary |
| Oct 27, 2011 | TSRX | $12.6K | Sale | 1,687 | $7.45 | Discretionary |
| Oct 27, 2011 | TSRX | $12.6K | Sale | 1,687 | $7.45 | Discretionary |
| Oct 4, 2011 | TSRX | $2.1K | Option Exercise | 4,000 | $0.52 | Discretionary |
| Aug 22, 2011 | TSRX | $2.1K | Option Exercise | 4,070 | $0.52 | Discretionary |